Six days after a senior FDA official sent a sweeping internal email claiming that COVID vaccines had caused the deaths of "at ...

The FDA has been rumored to be evaluating whether or not to place a black box warning on vaccines for COVID-19.

After patient deaths from interstitial lung disease in a lung cancer trial testing the antibody-drug conjugate ifinatamab deruxtecan, the FDA placed a partial hold on Daiichi Sankyo and Merck's global ...

A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts ...

As 2025 closes, biopharma and healthcare are learning to live on shifting ground. | Fierce reporters break down the forces that shaped biopharma and healthcare in 2025 and what lies ahead in 2026.

The Trump administration has announced sweeping policies that, if enacted, could effectively end gender-affirming care for ...

UNC's Barry Popkin joins Aaron to discuss the health impacts of "ultra-processed foods" and what policymakers should be doing ...

Biostatistician Jeffrey Morris discusses his analysis of the vaccine monitoring system — and how it could be improved.

The agency’s high-level turnover and conflicting policy decisions on drug oversight have fueled concerns about the leadership ...

A monkeypox vaccine or antibody therapy may have taken a step closer to reality, as AI reveals new drug target.

The US Department of Health and Human Services is planning to overhaul the schedule of recommended vaccines for children in ...

Dr. Vinay Prasad: "The establishment, the people who set the policies, they have to strive to get things right. They need to do studies. They need to be held to the highest standard." ...